Compound details
1-Phenylethanol
| Compound ID | CDAMM02909 |
|---|---|
| Common name | 1-Phenylethanol | IUPAC name | 1-phenylethanol |
| Molecular formula | C8H10O |
| Retention time | 14.27 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 145.063 | Theoretical mz | 145.062 |
| Error | 6.08 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.1398 |
| Inchi key | WAPNOHKVXSQRPX-UHFFFAOYNA-N |
|---|---|
| Smiles | OC(C=1C=CC=CC1)C |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q16853 | AOC3 | Amine oxidase, copper containing | T69619 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P08473 | MME | Neprilysin | T05409 | SEA |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SEA |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SEA |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| P10145 | CXCL8 | Interleukin-8 | T22658 | SEA |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SEA |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SEA |
| Q6DWJ6 | GPR139 | Probable G-protein coupled receptor 139 | T84439 | SEA |
| P35499 | SCN4A | Sodium channel protein type IV alpha subunit | T02546 | SEA |
| P15169 | CPN1 | Carboxypeptidase N, catalytic subunit | T34471 | SEA |
| P09172 | DBH | Dopamine beta hydroxylase | T74937 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T69619 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q16853 | AOC3 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T22658 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P10145 | CXCL8 |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T84439 | DI0377 | Sex development malformative disorder | [ICD-11: LD2A] | Q6DWJ6 | GPR139 |
| T02546 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | P35499 | SCN4A |
| T74937 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P09172 | DBH |
| T74937 | DI0341 | Post-traumatic stress disorder | [ICD-11: 6B40] | P09172 | DBH |